KOBIOLABS kobiolabs.com


Public lists: Genomics (520)

KOBIOLABS (고바이오랩) is developing solutions in microbiome analysis, probiotics, and microbiome therapeutics. The company researches the specific genetic sequences of the gut microbiome related to these diseases and uses this genetic information to develop a pathogenic or therapeutic microbial biomarker. Its objective is to use these biomarkers to evaluate the healthy gut microbial community and develop a rapid and precise diagnostic technology.

KOBIOLABS (고바이오랩) is developing solutions in microbiome analysis, probiotics, and microbiome therapeutics. The company researches the specific genetic sequences of the gut microbiome related to these diseases and uses this genetic informati...Show all

Company (Alive / Active)

Phone: +82 2 888-9937

Fax:

Seoul National University, Bio-MAX, #220, Room 630
1, Gwanak-ro, Gwanak-gu
Seoul, 08826
South Korea

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
KOBIOLABS $8.9M Aug 7, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related KOBIOLABS Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Lactobacillus sp. strain having ability to inhibit proliferation of virginal pathogenic microorganisms Mar 24, 2016 Application